Risk-related clinical outcomes after minimally invasive mitral valve surgery: insights from the Mini-Mitral International Registry.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 15 10 2022
revised: 13 02 2023
accepted: 08 03 2023
medline: 22 6 2023
pubmed: 10 3 2023
entrez: 9 3 2023
Statut: ppublish

Résumé

With the popularization of catheter-based mitral valve procedures, evaluating risk-specific differentiated clinical outcomes after contemporary mitral valve surgery is crucial. In this study, we assessed the operative results of minimally invasive mitral valve operations across different patient risk profiles and evaluated the value of EuroSCORE (ES) II predicted risk of mortality model for risk prediction, in the large cohort of Mini-Mitral International Registry (MMIR). The MMIR database was used to analyse mini-mitral operations between 2015 and 2021. Patients were categorized as low (<4%), intermediate (4% to <8%), high (8% to <12%) and extreme risk (≥12%) according to ES II. The observed-to-expected mortality ratio was calculated for each risk group. A total of 6541 patients were included in the analysis. Of those, 5546 (84.8%) were classified as low risk, 615 (9.4%) as intermediate risk, 191 (2.9%) as high risk and 189 (2.9%) as extreme risk. Overall operative mortality and stroke rates were 1.7% and 1.4%, respectively, and were significantly associated with patient's risk. The observed mortality was significantly lower than expected-according to the ES II-in all risk categories (observed-to-expected ratio < 1). The present study provides an international contemporary benchmark for operative outcomes after minimally invasive mitral surgery. Operative results were excellent in low-, intermediate- and high-risk patients, but were less satisfactory in extreme risk. The ES II model overestimated the in-hospital mortality. We believe that findings from the MMIR may assist surgeons and cardiologists in clinical decision-making and treatment allocation for patients with mitral valve disease.

Identifiants

pubmed: 36892446
pii: 7074178
doi: 10.1093/ejcts/ezad090
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Paolo Berretta (P)

Cardiac Surgery Unit, Lancisi Cardiovascular Center, Polytechnic University of Marche, Ancona, Italy.

Jorg Kempfert (J)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

Frank Van Praet (F)

Cardiac Surgery Department, Hartcentrum OLV Aalst, Aalst, Belgium.

Loris Salvador (L)

Division of Cardiac Surgery, S. Bortolo Hospital, Vicenza, Italy.

Joseph Lamelas (J)

Division of Cardiothoracic Surgery, University of Miami, Miami, FL, USA.

Tom C Nguyen (TC)

Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center Houston, McGovern Medical School, Houston, TX, USA.

Manuel Wilbring (M)

Center for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, Dresden, Germany.

Marc Gerdisch (M)

Franciscan Health Indianapolis, Indianapolis, IN, USA.

Mauro Rinaldi (M)

Cardiac Surgery Unit, University of Turin, Turin, Italy.

Nikolaos Bonaros (N)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Thierry Folliguet (T)

Henri Mondor Hospital, University of Paris, Paris, France.

Torsten Doenst (T)

Department of Cardiothoracic Surgery, Jena University Hospital, Jena, Germany.

Dinh Hoang Nguyen (DH)

University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam.

Pierluigi Stefano (P)

Cardiac Surgery Unit, Careggi University Hospital, Firenze, Italy.

Tristan Yan (T)

Department of Cardiothoracic Surgery, The Royal Prince Alfred Hospital, Sydney, Australia.

Carlo Savini (C)

Cardiac Surgery Department, Sant'Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.

Antonios Pitsis (A)

Cardiac Surgery Department, European Interbalkan Medical Center, Thessaloniki, Greece.

Marco Di Eusanio (M)

Cardiac Surgery Unit, Lancisi Cardiovascular Center, Polytechnic University of Marche, Ancona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH